The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #12 is a biotech by the name of Black Diamond Therapeutics (BDTX). The reason why I want to go over this ...
The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #11 is a biotech by the name of Vistagen Therapeutics (VTGN). The reason why I want to go over this ...
Sovereign capital, guaranteed offtake, and localization mandates are reshaping how biotech deals get structured in the Gulf, ...
Biotechnology organizations are turning in growing numbers to alternative strategies centered on strengthening the performance of already-approved drugs. Oncotelic Therapeutics is developing ...
CAMARILLO, Calif., July 29, 2026 /PRNewswire/ -- PBS Biotech, a leader in advanced cell therapy manufacturing technologies, today announced its membership in Organoid COMMONS. As a member of this ...
After 15 years at Genentech, where his work has spanned small molecules, antibody drug conjugates, and now cell and gene therapies – Don has become one of the company’s most vocal champions for the ...
A homegrown sovereign biotech AI has emerged to challenge Google DeepMind's AlphaFold3. KAIST announced Friday that Team ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results